Answers are grounded in this paper and cite their sources.
Examines antihypertensive treatment effects on maternal and fetal risks during pregnancy, suggesting guidelines for clinicians.
The decision to treat elevated arterial pressure in pregnancy depends on the risk and benefits imposed on the mother and the fetus. Treatment for mild-to-moderate hypertension during pregnancy may not reduce maternal or fetal risk. Severe hypertension, on the other hand, should be treated to decrease maternal risk. Methyldopa and beta-adrenoceptor antagonists have been used most extensively. In acute severe hypertension, intravenous labetalol or oral nifedipine are reasonable choices.
No takes yet. Share an insight, caveat, or question.
Ghanem et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: